Akari Therapeutics PLC
Change company Symbol lookup
Select an option...
AKTX Akari Therapeutics PLC
DMPI DelMar Pharmaceuticals Inc
FLR Fluor Corp
SPLK Splunk Inc
LB L Brands Inc
TEAM Atlassian Corporation PLC
GRAS Greenfield Farms Food Inc
CMS CMS Energy Corp
BAC Bank of America Corp
HPQ HP Inc
Go

Health Care : Pharmaceuticals |
Based in United KingdomCompany profile

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal hemoglobinuria, Guillain Barre syndrome and atypical Hemolytic Uremic Syndrome. Its lead drug, Coversin, a complement inhibitor, acts on complement C5, preventing release of C5a and formation of C5b-9. Coversin is a recombinant small protein derived from a protein discovered in the saliva of the Ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response. It is conducting Phase Ib clinical trial of Coversin. It focuses on rare and orphan diseases, including disease states spanning hematology, nephrology, transplantation, neurology and ophthalmology.

Price
Delayed
$2.42
Day's Change
0.0053 (0.22%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.48
Day's Low
2.34
Volume
(Light)

Today's volume of 32,666 shares is on pace to be much lighter than AKTX's 10-day average volume of 137,735 shares.

32,666
  • Prev Close
    2.41
  • Today's Open
    2.39
  • Day's Range
    2.34-2.48
  • Avg Vol (10-day)
    137.7K
  • Last (time)
    12:37p ET 05/23/19
  • Last (size)
    273
  • 52-Wk Range
    1.56 - 9.20
    LowHigh
  • (12/31/18 - 03/14/19)
    54.83%
  • 139.7%
  • Market Cap
    38.3M
  • Shares Outstanding
    15.9M
  • -1.07
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • -3.4
  • 5.62
  • (% of float 04/30/19)
    584.37

Latest News

April 26, 2019
8:48 am ET
Globe Newswire
April 24, 2019
9:31 am ET
PR Newswire
April 23, 2019
4:01 pm ET
Globe Newswire
8:30 am ET
Globe Newswire
April 15, 2019
8:30 am ET
Globe Newswire
March 27, 2019
4:14 pm ET
Globe Newswire
March 14, 2019
9:40 am ET
MarketWatch
9:31 am ET
PR Newswire
8:30 am ET
PR Newswire
8:04 am ET
MarketWatch
March 13, 2019
10:35 am ET
MarketWatch
8:29 am ET
Globe Newswire
January 04, 2019
9:26 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.